Publication:
The role of nitric oxide in the reversal of hemorrhagic shock by oxotremorine

dc.contributor.authorsGoren, MZ; Akici, A; Karaalp, A; Aker, R; Oktay, S
dc.date.accessioned2022-03-12T16:58:07Z
dc.date.accessioned2026-01-10T18:47:37Z
dc.date.available2022-03-12T16:58:07Z
dc.date.issued2001
dc.description.abstractIn the present study, the effect of the nitric oxide synthase inhibitor, N-G-nitro-L-arginine methylester (L-NAME), on the antishock actions of oxotremorine was investigated in rats subjected to hemorrhagic shock under urethane anesthesia. L-citrulline production in the AV3V region, as an indicator of nitric oxide (NO) synthesis, was assayed by hi.-h-performance liquid chromatography (HPLC with fluorescent detection throughout the experiment. The rats were pretreated with either intravenous (i.v.) physiological saline or L-NAME (2.5 mg/kg) before bleeding. L-NAME potentiated the reversal of hypotension by oxotremorine (25 mug/kg, i.v.). However, oxotremorine either alone or in combination with L-NAME did not produce any significant change in 60-min survival rate at this low dose. Analysis of microdialysis samples collected from the AV3V region showed that L-citrulline concentration increased during bleeding and that this increase was abolished by L-NAME pretreatment, These results may suggest that nitric oxide production contributes to hypotension in rats bled to shock since nitric oxide levels in the AV3V region increased in response to bleeding and nitric oxide synthase (NOS) inhibition abolished this increase and potentiated the oxotremorine-induced reversal of hypotension. (C) 2001 Elsevier Science B.V. All rights reserved.
dc.identifier.doi10.1016/S0014-2999(01)01294-8
dc.identifier.issn0014-2999
dc.identifier.pubmed11675044
dc.identifier.urihttps://hdl.handle.net/11424/227011
dc.identifier.wosWOS:000171653700014
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofEUROPEAN JOURNAL OF PHARMACOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectanteroventral third ventricle region
dc.subjecthemorrhagic shock
dc.subjectL-citrulline
dc.subjectN-G-nitro-L-arginine methylester (L-NAME)
dc.subjectmicrodialysis
dc.subjectmuscarinic receptor
dc.subjectnitric oxide (NO)
dc.subjectoxotremorine
dc.subject(rat)
dc.subjectPRESSOR-RESPONSE
dc.subjectCHOLINERGIC MECHANISMS
dc.subjectHYPERTENSIVE RESPONSE
dc.subjectCHOLINOMIMETIC DRUGS
dc.subjectCHRONIC INHIBITION
dc.subjectBLOOD-PRESSURE
dc.subjectAV3V REGION
dc.subjectRAT
dc.subjectSTIMULATION
dc.subjectCARBACHOL
dc.titleThe role of nitric oxide in the reversal of hemorrhagic shock by oxotremorine
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage267
oaire.citation.issue2
oaire.citation.startPage261
oaire.citation.titleEUROPEAN JOURNAL OF PHARMACOLOGY
oaire.citation.volume428

Files